SCHEMBL8919081

SCHEMBL8919081

CN1CCN(Cc2cnc3c(c2)oc(=O)n3C)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1B Q01064 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.39
KDM4E B2RXH2 2/20 0.39
TSHR P16473 1/20 0.39
MC4R P32245 1/20 0.39
HTR1A P08908 2/20 0.38
HTR7 P34969 2/20 0.38
HTR6 P50406 2/20 0.38
ALDH1A1 P00352 2/20 0.38
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
NR4A2 P43354 1/20 0.38
DCTPP1 Q9H773 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8917938 0.88 PDE1B (0.43) PDE1BSMN1; SMN2KDM4EALDH1A1DCTPP1
SCHEMBL8918497 0.85 DRD4 (0.53) HTR1AHTR7ALDH1A1
SCHEMBL8918622 0.79 HRH3 (0.41) HTR1A
SCHEMBL8624806 0.77 HSD17B10 (0.35) SMN1; SMN2KDM4ETSHRALDH1A1HPGD
SCHEMBL8918611 0.77 SIGMAR1 (0.41) SMN1; SMN2TSHRHTR1AALDH1A1NOS3
SCHEMBL8628216 0.75 PDE10A (0.35) SMN1; SMN2KDM4ETSHRALDH1A1HPGD
SCHEMBL8917996 0.75 SIGMAR1 (0.44) SMN1; SMN2HTR1AALDH1A1HPGDHSD17B10
SCHEMBL8919271 0.74 ALDH1A1 (0.53) KDM4ETSHRALDH1A1HPGD
SCHEMBL8918424 0.74 HTR1A (0.51) HTR1AHTR7
SCHEMBL7326070 0.74 ALDH1A1 (0.35) SMN1; SMN2KDM4ETSHRALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5618819-A ANALGESICS ADIR ET COMPAGNIE (FR) 1997-04-08 US disclosed
EP-0691339-A1 Amine derivatives of 1,3-dihydro-2H-pyrrolo(2,3-b)pyridin-2-ones and oxazolo(4,5-b)pyridin-2(3H)-ones, their process of preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1996-01-10 EP disclosed